CLAGETT-DAME MARGARET has a total of 23 patent applications. Its first patent ever was published in 2004. It filed its patents most often in WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are DELUCA HECTOR F, KISSEI PHARMACEUTICAL COMPANY and BAGI RES LIMITED.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 18 | |
#2 | United States | 5 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Clagett-Dame Margaret | 23 |
#2 | Deluca Hector F | 20 |
#3 | Plum Lori A | 16 |
#4 | Sicinski Rafal R | 7 |
#5 | Glebocka Agnieszka | 5 |
#6 | Nieves Nirca J | 4 |
#7 | Grzywacz Pawel | 3 |
#8 | Sokolowska Katarzyna | 3 |
#9 | Kaiser Mary E | 2 |
#10 | Tadi Bulli Padmaja | 2 |
Publication | Filing date | Title |
---|---|---|
WO2011041579A2 | (20S,22E)-2-METHYLENE-19-NOR-22-ENE-1α,25-DIHYDROXYVITAMIN D3 ANALOGS | |
WO2011041599A2 | 6-methylvitamin d3 analogs and their uses | |
US2011003892A1 | All-trans retinoid esters as active pharmaceutical ingredients, oral and topical dosage form compositions thereof, and methods of treating skin conditions thereof | |
US2008261925A1 | Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog | |
WO2004064743A2 | Modified retinoid compounds and their uses |